Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes

PURPOSE: Metformin is the first-line antidiabetic drug and shown to reduce cardiovascular risk independent from its glucose lowering action. Particularly in poorly controlled diabetes, tissue factor (TF) is expressed in the vasculature and accounts for thromboembolic complications. Here, we aimed to...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cardiovasc Drugs Ther
Huvudupphovsmän: Witkowski, Marco, Friebel, Julian, Tabaraie, Termeh, Grabitz, Sinah, Dörner, Andrea, Taghipour, Lena, Jakobs, Kai, Stratmann, Bernd, Tschoepe, Diethelm, Landmesser, Ulf, Rauch, Ursula
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer US 2020
Ämnen:
Short Communication
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8266708/
https://ncbi.nlm.nih.gov/pubmed/32940892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-020-07040-7
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk